Cintas Corp. (CTAS) Tops Q3 EPS by 10c, Offers Guidance
Get Alerts CTAS Hot Sheet
Price: $201.19 -1.14%
Revenue Growth %: +9.6%
Financial Fact:
Total revenue: 1.29B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Revenue Growth %: +9.6%
Financial Fact:
Total revenue: 1.29B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cintas Corp. (NASDAQ: CTAS) reported Q3 EPS of $3.14, $0.10 better than the analyst estimate of $3.04. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.15 billion.
GUIDANCE:
Cintas Corp. sees FY2023 EPS of $12.70-$12.90, versus the consensus of $12.73. Cintas Corp. sees FY2023 revenue of $8.74-8.8 billion, versus the consensus of $8.73 billion.
For earnings history and earnings-related data on Cintas Corp. (CTAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share